Cancer Tech Startup Ezra Raised $18 Million Right Before The Pandemic—Now It’s Pivoting To Covid-19 Screening After the coronavirus lockdown froze its cancer-screening business, startup Ezra has shifted focus to testing for Covid-19 damage.